0917 GMT - Fevertree Drinks' partnership with Molson Coors reduces the potential impact over time from the U.S. tariffs, RBC Capital Markets analysts Tania Maciver and Ashnaa Vyas say in a note. However, investors might not see the benefits so soon, given that following the deal--where Molson Coors will handle U.S. operations--, Fevertree has entered into a transition period of increased investment in marketing to boost U.S. sales and distribution network, they say. This means revenue and profit are forecast to grow only after 2026, the analysts add. Prior to the partnership, the London-listed mixer-maker in 2024 already increased its market share in the U.S. in the total mixer category, they say. The company also took market share in tonics and in ginger beer segment, currently at 27% and 32%, respectively. Shares are up 1.3%. (michael.susin@wsj.com)
(END) Dow Jones Newswires
April 04, 2025 05:17 ET (09:17 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.